# TCF19

## Overview
TCF19 is a gene that encodes the transcription factor 19, a protein involved in regulating gene expression related to cell cycle progression, immune responses, and DNA repair. The protein is characterized by the presence of a plant homeodomain (PHD) finger and a forkhead-associated (FHA) domain, which facilitate its interaction with chromatin and other proteins, thereby influencing cellular processes such as cell proliferation and immune function (Mondal2019TCF19; Yang2021TCF19). TCF19 is expressed in various tissues, including pancreatic β-cells and germinal center cells, where it plays a crucial role in maintaining cellular homeostasis and responding to DNA damage (Cheung2010Conditional; Yang2021TCF19). Alterations in the TCF19 gene have been linked to several diseases, including multiple myeloma and hepatocellular carcinoma, highlighting its clinical significance as a potential biomarker and therapeutic target (Macauda2016Identification; Wang2024Transcription).

## Structure
TCF19, or transcription factor 19, is a protein characterized by specific structural domains that contribute to its function in cell proliferation. The protein contains a plant homeodomain (PHD) finger and a forkhead-associated (FHA) domain, which are crucial for its role in transcriptional regulation (Mondal2019TCF19). The PHD finger of TCF19 is particularly important for recognizing the trimethylated lysine 4 of histone 3 (H3K4me3), a key interaction that mediates cell proliferation in liver cancer cells (Mondal2019TCF19). 

The PHD finger domain includes an aromatic cage formed by residues W307 and W316, which are essential for binding to H3K4me3. Mutations in these residues significantly disrupt this binding, highlighting the sensitivity of the PHD finger's structure to changes (Mondal2019TCF19). Nuclear Magnetic Resonance (NMR) studies have been used to analyze the binding interactions of the PHD finger with histone peptides, providing insights into its structural configuration (Mondal2019TCF19).

While the primary structure of TCF19, including its amino acid sequence, is not detailed in the provided context, the presence of these domains suggests a complex tertiary structure that facilitates its role in gene regulation. Information on post-translational modifications or splice variant isoforms is not available in the context provided.

## Function
The TCF19 gene encodes a transcription factor involved in several critical cellular processes, particularly in the regulation of gene expression related to cell cycle progression and immune responses. TCF19 is expressed in human islets and is associated with the proliferation and survival of pancreatic β-cells. Its knockdown has been shown to impair β-cell proliferation and induce cell cycle arrest, highlighting its role in maintaining normal cell cycle progression (Yang2021TCF19).

TCF19 contains a forkhead-associated (FHA) domain and a plant homeodomain (PHD) finger, which facilitate its interaction with chromatin and involvement in DNA repair and cell cycle regulation (Yang2021TCF19). Overexpression of TCF19 in β-cells leads to increased expression of DNA damage response (DDR) genes and genes involved in inflammation and antiviral responses, suggesting its role in modulating these pathways without directly inducing cell proliferation (Yang2021TCF19).

In addition to its role in cell cycle and DNA repair, TCF19 is implicated in immune system processes. It is up-regulated in human pro-B and pre-B cells and is highly expressed in germinal center cells, indicating its potential involvement in maintaining immunological balance (Cheung2010Conditional). These functions underscore TCF19's importance in cellular homeostasis and its potential impact on organismal health.

## Clinical Significance
Mutations and alterations in the TCF19 gene have been implicated in several diseases and conditions. In the context of hearing loss, a specific variant, c.482G > A, which results in an arginine to glutamine substitution at position 161, has been identified. This mutation affects the protein's charge and disrupts its normal function, potentially leading to hearing loss due to its role in cochlear development and function (Mohseni2021Exome). TCF19 has also been associated with multiple myeloma (MM). A single nucleotide polymorphism (SNP) within TCF19, rs1419881, has shown a potential association with MM risk, suggesting that genetic variations in TCF19 may influence the pathogenesis of this disease (Macauda2016Identification).

In hepatocellular carcinoma (HCC), TCF19 is one of the transcription factors identified as having prognostic value. Its expression is upregulated in HCC tissues, and it is associated with drug resistance, particularly to the chemotherapeutic agent trametinib. This suggests that TCF19 may play a role in HCC progression and could serve as a potential drug target (Wang2024Transcription). Additionally, genetic variants in TCF19 have been linked to susceptibility to chronic hepatitis B virus (HBV) infection, indicating its involvement in the immune response to viral infections (Matsuura2015Host).

## Interactions
TCF19 is involved in various interactions that influence cellular processes, particularly in pancreatic β-cells and hepatocellular carcinoma (HCC). In pancreatic β-cells, TCF19 overexpression leads to the upregulation of genes involved in DNA damage response (DDR) and inflammatory pathways. This suggests that TCF19 may interact with transcriptional co-regulators such as STAT1, STAT2, and IRF1, although direct modulation of these factors' activation was not observed (Yang2021TCF19). TCF19's interaction with chromatin is facilitated by its plant homeodomain (PHD) finger, which binds to tri-methylated histone H3, indicating a role in transcriptional regulation through chromatin modification (Yang2021TCF19).

In HCC, TCF19 is implicated in promoting cell proliferation and tumorigenesis by activating the AKT/FOXO1 signaling pathway. This involves interactions that lead to increased phosphorylation of FOXO1 and AKT, affecting the expression of cell cycle regulators such as cyclin D1 and suppressors like p21 Cip1 and p27 Kip1 (Zeng2019TCF19). These interactions highlight TCF19's role in modulating key signaling pathways that drive cell cycle progression and proliferation in cancerous tissues. The presence of a forkhead-associated (FHA) domain in TCF19 suggests potential interactions with phospho-epitopes on proteins involved in DDR, such as ATM and ATR, further supporting its role in DNA repair processes (Yang2021TCF19).


## References


[1. (Matsuura2015Host) Kentaro Matsuura, Masanori Isogawa, and Yasuhito Tanaka. Host genetic variants influencing the clinical course of hepatitis b virus infection. Journal of Medical Virology, 88(3):371–379, August 2015. URL: http://dx.doi.org/10.1002/jmv.24350, doi:10.1002/jmv.24350. This article has 41 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jmv.24350)

[2. (Macauda2016Identification) Angelica Macauda, Diego Calvetti, Giuseppe Maccari, Kari Hemminki, Asta Försti, Hartmut Goldschmidt, Niels Weinhold, Richard Houlston, Vibeke Andersen, Ulla Vogel, Gabriele Buda, Judit Varkonyi, Anna Sureda, Joaquin Martinez Lopez, Marzena Watek, Aleksandra Butrym, Maria Eugenia Sarasquete, Marek Dudziński, Artur Jurczyszyn, Agnieszka Druzd-Sitek, Marcin Kruszewski, Edyta Subocz, Mario Petrini, Elzbieta Iskierka-Jażdżewska, Malgorzata Raźny, Gergely Szombath, Herlander Marques, Daria Zawirska, Dominik Chraniuk, Janusz Halka, Svend Erik Hove Jacobsen, Grzegorz Mazur, Ramón García Sanz, Charles Dumontet, Victor Moreno, Anna Stępień, Katia Beider, Matteo Pelosini, Rui Manuel Reis, Malgorzata Krawczyk-Kulis, Marcin Rymko, Hervé Avet-Loiseau, Fabienne Lesueur, Norbert Grząśko, Olga Ostrovsky, Krzysztof Jamroziak, Annette J. Vangsted, Andrés Jerez, Waldemar Tomczak, Jan Maciej Zaucha, Katalin Kadar, Juan Sainz, Arnon Nagler, Stefano Landi, Federica Gemignani, and Federico Canzian. Identification of mirsnps associated with the risk of multiple myeloma: identification of mirsnps associated with the risk of multiple myeloma. International Journal of Cancer, 140(3):526–534, November 2016. URL: http://dx.doi.org/10.1002/ijc.30465, doi:10.1002/ijc.30465. This article has 8 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ijc.30465)

[3. (Yang2021TCF19) Grace Yang, Danielle Fontaine, Sukanya Lodh, Joseph Blumer, Avtar Roopra, and Dawn Davis. Tcf19 impacts a network of inflammatory and dna damage response genes in the pancreatic β-cell. Metabolites, 11(8):513, August 2021. URL: http://dx.doi.org/10.3390/metabo11080513, doi:10.3390/metabo11080513. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/metabo11080513)

[4. (Zeng2019TCF19) C. X. Zeng, S. B. Fu, W. S. Feng, J. Y. Zhao, F. X. Li, and P. Gao. Tcf19 enhances cell proliferation in hepatocellular carcinoma by activating the atk/foxo1 signaling pathway. Neoplasma, 66(01):46–53, 2019. URL: http://dx.doi.org/10.4149/neo_2018_171227n845, doi:10.4149/neo_2018_171227n845. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.4149/neo_2018_171227n845)

[5. (Mohseni2021Exome) Marzieh Mohseni, Mojgan Babanejad, Kevin T. Booth, Payman Jamali, Khadijeh Jalalvand, Behzad Davarnia, Fariba Ardalani, Atefeh Khoshaeen, Sanaz Arzhangi, Fatemeh Ghodratpour, Maryam Beheshtian, Faezeh Jahanshad, Hasan Otukesh, Fatemeh Bahrami, Seyed Morteza Seifati, Niloofar Bazazzadegan, Farkhonde Habibi, Hanieh Behravan, Sepide Mirzaei, Fatemeh Keshavarzi, Nooshin Nikzat, Zohreh Mehrjoo, Holger Thiele, Michael Nothnagel, Hela Azaiez, Richard J. Smith, Kimia Kahrizi, and Hossein Najmabadi. Exome sequencing utility in defining the genetic landscape of hearing loss and novel‐gene discovery in iran. Clinical Genetics, 100(1):59–78, March 2021. URL: http://dx.doi.org/10.1111/cge.13956, doi:10.1111/cge.13956. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cge.13956)

[6. (Wang2024Transcription) Meixia Wang, Hanyao Guo, Bo Zhang, Yanan Shang, Sidi Zhang, Xiaoyu Liu, Pengxiu Cao, Yumei Fan, and Ke Tan. Transcription factors-related molecular subtypes and risk prognostic model: exploring the immunogenicity landscape and potential drug targets in hepatocellular carcinoma. Cancer Cell International, January 2024. URL: http://dx.doi.org/10.1186/s12935-023-03185-1, doi:10.1186/s12935-023-03185-1. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12935-023-03185-1)

[7. (Cheung2010Conditional) Yee Him Cheung, John Watkinson, and Dimitris Anastassiou. Conditional meta-analysis stratifying on detailed hla genotypes identifies a novel type 1 diabetes locus around tcf19 in the mhc. Human Genetics, 129(2):161–176, November 2010. URL: http://dx.doi.org/10.1007/s00439-010-0908-2, doi:10.1007/s00439-010-0908-2. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-010-0908-2)

[8. (Mondal2019TCF19) Payel Mondal, Sabyasachi Sen, Brianna J. Klein, Niharika Tiwary, Shrikanth S. Gadad, Tatiana G. Kutateladze, Siddhartha Roy, and Chandrima Das. Tcf19 promotes cell proliferation through binding to the histone h3k4me3 mark. Biochemistry, 59(4):389–399, November 2019. URL: http://dx.doi.org/10.1021/acs.biochem.9b00771, doi:10.1021/acs.biochem.9b00771. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.biochem.9b00771)